You are here:
  1. Homepage
  2. News and insights
  3. Events
  4. Autoinjector development comes into focus in Suzhou, China

Autoinjector development comes into focus in Suzhou, China

February 03 2026

APAC
[.jpg] Suzhou city skyline, where SHL Medical will participate in a pharma autoinjector conference in Suzhou, China.
In Suzhou, discussions on autoinjector development reflect the growing intersection of global scale and local execution.

SHL Medical will participate in the 2026 Pre-Filled Syringe (PFS) and Precision Dosing Innovation Conference, taking place March 5-6 in Suzhou, China. The conference brings together pharma and device leaders to examine the evolving role of autoinjector, precision dosing, and drug-device combination products in modern therapy programs.

With operations spanning three continents and a dedicated team based in Shanghai, we work with pharma and biotech companies worldwide to support autoinjector programs from development through launch, building long-term strategic partnerships across both global and local portfolios.

SHL Medical’s global footprint reflects more than three decades of experience supporting drug-device combination products at scale. Today, SHL Medical’s autoinjector solutions are in use across multiple markets, including China, where – according to IQVIA data – they account for close to half of the autoinjector market. The result is an established presence within China’s autoinjector ecosystem, shaped by execution capability, consistent quality, and strategic collaboration.


Used across multiple therapy programs, Molly is recognized for its flexible design and consistent manufacturing quality.

At the conference in Suzhou, China, we will present our device portfolio, including the Molly autoinjector platforms, Reunite dual-chamber cartridge autoinjector, and Maggie large-volume cartridge-based autoinjectors. In a dedicated speaking session, we will discuss how experiences gained from global combination product programs can inform autoinjector development and execution in the China market.

Our team will be available at Booth #11A, where discussions will focus on how global autoinjector expertise, combined with local collaboration in China, can support the successful delivery of drug-device combination product development.


Meet our speaker

Topic

Speaker

Time

Navigating Autoinjector Development in China: Insights from Global Combination Product Experience

Steve Zhou

Business Development Director, SHL Medical

March 5

2:30 PM CST


Where  : Hotel Nikko Suzhou, Suzhou, China | Booth #11A

When   : March 5-6